Symposium:
122. Nightmare Cases and Hot Mechanisms of Resistance
Friday, October 9, 2015: 10:30 AM-12:00 PM
Room: 6--CF

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the clinical impact of emerging mechanisms of resistance to selected pathogens using real clinical cases
  • examine the mechanistic basis for antibiotic choices in resistant bacterial and fungal pathogens
  • assess the consequences of emerging resistance on patient outcome

Target Audience: Scientists, Researchers, Pharmacists, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, Epidemiology and Infection Control, Adult ID, Trainee

Moderators:  Cesar Arias, MD, PhD, FIDSA, University of Texas Medical School at Houston and Maria Virginia Villegas, MD, MSc, FIDSA, Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM)

Presentations:
10:30 AM
716
Gram-Positives
Jose Munita, MD
11:00 AM
717
Gram-Negatives
Maria Virginia Villegas, MD, MSc, FIDSA

11:30 AM
718
Fungi
John Baddley, MD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-175-L01-P

Disclosures:

C. Arias, Pfizer: Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Merck Sharp and Dohme: Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Cubist: Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Theravance: Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Bayer: Consultant , Consulting fee

M. V. Villegas, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.